Natera’s Multi-Cancer Blood Test Gets FDA Breakthrough Status, a Faster Review Path That Is Not an Approval

Natera’s multi-cancer blood test won FDA breakthrough status, which is not an approval. What it means, what data are missing, and what to ask.

Have A Referral?